Ignite Creation Date:
2024-05-06 @ 6:41 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05749211
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-05-16
First Post:
2023-01-19
Brief Title:
Huaier Granule in Combination With Nilaparil in Therapy Patients With Stage IIIIV BRCA Wild-type Ovarian Cancer
Sponsor:
Ruijin Hospital
Organization:
Ruijin Hospital
Study Overview
Official Title:
Efficacy and Safety of Huaier Granule in Combination With Nilaparil in First-line Maintenance Therapy in Postoperative Patients With Stage IIIIV BRCA Wild-type Ovarian Cancer a Single-center Prospective Single-arm Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a single-center prospective single-arm clinical trial to evaluate the efficacy and safety of Huaier granules in combination with immunotargeted agents in postoperative patients with ovarian cancer
Detailed Description:
Primary objective
1 To evaluate the efficacy of Huaier granule combined with immunotargeted drugs in the treatment of postoperative ovarian cancer patients
Secondary objectives
1To analyze the safety of Huaier granule in the treatment of postoperative ovarian cancer patients 22 To analyze the influence of Huaier granule on postoperative quality of life of patients with ovarian cancer
1 To evaluate the efficacy of Huaier granule combined with immunotargeted drugs in the treatment of postoperative ovarian cancer patients
Secondary objectives
1To analyze the safety of Huaier granule in the treatment of postoperative ovarian cancer patients 22 To analyze the influence of Huaier granule on postoperative quality of life of patients with ovarian cancer
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None